Icon
+91 94997 68112
Login Register

CILOXAN (nda019992)- (EQ 0.3% BASE)

CIPROFLOXACIN HYDROCHLORIDE SANDOZ
EQ 0.3% BASE
No No
2004-Jun-09 Expired
None None
None No
CILOXAN Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus (Viridans Group), Conjunctivitis: Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae.
6 0 5
Total Other Developers None
Drugs with Suitability No
EQ 0.3% BASE ** ** - 1 -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******** ****** ***** ********* ******* *** (*** *****) *********** **** **** ***** ***., *******, ******** (**) *****, ****** ****** (***) ***
****** ******** ****** ***** ********* ******* *** (*** *****) *********** ** ******** *** *** *, ********, *** ****** (**) *****-****, ****** ****** (***) ***
****** *** *** *** ******* *********** *-*,**** ********** ****, *****, **********, *********** ******, ***** (***) ***
****** ****** ****** ******** ******* *********** *** *****-** & ***, *-**,**,**, ***** ********** ****, *****,, ***, *** ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.